These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 11032176

  • 21. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O'Rahilly S, Palmer CN, Plutzky J, Reddy JK, Spiegelman BM, Staels B, Wahli W.
    Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
    [Abstract] [Full Text] [Related]

  • 22. Peroxisome proliferator-activated receptors (PPARs) in health and disease.
    Ehrmann J, Vavrusová N, Collan Y, Kolár Z.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2002 Dec; 146(2):11-4. PubMed ID: 12572888
    [Abstract] [Full Text] [Related]

  • 23. Peroxisome proliferator-activated receptors: a family of lipid-activated transcription factors.
    Clarke SD, Thuillier P, Baillie RA, Sha X.
    Am J Clin Nutr; 1999 Oct; 70(4):566-71. PubMed ID: 10500027
    [Abstract] [Full Text] [Related]

  • 24. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology.
    Lemberger T, Desvergne B, Wahli W.
    Annu Rev Cell Dev Biol; 1996 Oct; 12():335-63. PubMed ID: 8970730
    [Abstract] [Full Text] [Related]

  • 25. [Peroxisome proliferator-activated receptor gamma (PPAR gamma)].
    Sugiyama E, Tanaka N, Aoyama T.
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():305-8. PubMed ID: 11351594
    [No Abstract] [Full Text] [Related]

  • 26. [Peroxisome proliferator activated nuclear receptors: possible role in the development of atherosclerosis].
    Evdokimova MA, Zateĭshchikov DA, Sidorenko BA.
    Kardiologiia; 2003 Feb; 43(11):41-8. PubMed ID: 14671562
    [Abstract] [Full Text] [Related]

  • 27. The peroxisome proliferator-activated receptor(PPARgamma) as a regulator of monocyte/macrophage function.
    Ricote M, Huang JT, Welch JS, Glass CK.
    J Leukoc Biol; 1999 Nov; 66(5):733-9. PubMed ID: 10577502
    [Abstract] [Full Text] [Related]

  • 28. An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer.
    Gelman L, Fruchart JC, Auwerx J.
    Cell Mol Life Sci; 1999 Jun; 55(6-7):932-43. PubMed ID: 10412372
    [Abstract] [Full Text] [Related]

  • 29. Peroxisome proliferator-activated receptors and inflammation: from basic science to clinical applications.
    Chinetti G, Fruchart JC, Staels B.
    Int J Obes Relat Metab Disord; 2003 Dec; 27 Suppl 3():S41-5. PubMed ID: 14704743
    [Abstract] [Full Text] [Related]

  • 30. Medical significance of peroxisome proliferator-activated receptors.
    Vamecq J, Latruffe N.
    Lancet; 1999 Jul 10; 354(9173):141-8. PubMed ID: 10408502
    [Abstract] [Full Text] [Related]

  • 31. [Significance of PPAR gamma(peroxisome proliferator-activated receptor gamma) in hypertension and its vascular complications].
    Itoh H, Nakao K.
    Nihon Rinsho; 2000 Jan 10; 58 Suppl 1():214-24. PubMed ID: 11026267
    [No Abstract] [Full Text] [Related]

  • 32. Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis.
    Vanden Heuvel JP.
    Toxicol Sci; 1999 Jan 10; 47(1):1-8. PubMed ID: 10048147
    [Abstract] [Full Text] [Related]

  • 33. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging.
    Pineda Torra I, Gervois P, Staels B.
    Curr Opin Lipidol; 1999 Apr 10; 10(2):151-9. PubMed ID: 10327283
    [Abstract] [Full Text] [Related]

  • 34. [The anti-atherogenic role of peroxisome proliferator activated receptors (PPARs)].
    Skoczyńska A, Poreba R, Sieradzki A, Turczyn B.
    Pol Arch Med Wewn; 2002 Nov 10; 108(5):1125-31. PubMed ID: 12685256
    [No Abstract] [Full Text] [Related]

  • 35. Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis.
    Fajas L, Debril MB, Auwerx J.
    J Mol Endocrinol; 2001 Aug 10; 27(1):1-9. PubMed ID: 11463572
    [Abstract] [Full Text] [Related]

  • 36. Therapeutic role of peroxisome proliferator-activated receptors in obesity, diabetes and inflammation.
    Ram VJ.
    Prog Drug Res; 2003 Aug 10; 60():93-132. PubMed ID: 12790340
    [Abstract] [Full Text] [Related]

  • 37. Peroxisome proliferator-activated receptors: a critical link among fatty acids, gene expression and carcinogenesis.
    Vanden Heuvel JP.
    J Nutr; 1999 Feb 10; 129(2S Suppl):575S-580S. PubMed ID: 10064336
    [Abstract] [Full Text] [Related]

  • 38. [PPARgamma and atheroma].
    Staels B.
    Ann Endocrinol (Paris); 2002 Apr 10; 63(2 Pt 2):1S23-6. PubMed ID: 12037504
    [Abstract] [Full Text] [Related]

  • 39. The potential role of peroxisome proliferator-activated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis.
    Plutzky J.
    Am J Cardiol; 2003 Aug 18; 92(4A):34J-41J. PubMed ID: 12957325
    [Abstract] [Full Text] [Related]

  • 40. Fatty acid regulation of gene expression.
    Grimaldi PA.
    Curr Opin Clin Nutr Metab Care; 2001 Sep 18; 4(5):433-7. PubMed ID: 11568506
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.